Victoza alternatives — what to ask your prescriber

Therapeutic alternatives, by category

Equivalence strength reflects shared mechanism of action plus the depth of head-to-head clinical evidence. Costs are US cash-price estimates and vary widely by pharmacy, insurance, and manufacturer copay programs.

FAQ

Is there a generic version of Victoza?

Yes. In June 2024 the FDA approved Teva Pharmaceuticals' generic liraglutide injection 6 mg/mL — the first FDA-approved generic of any GLP-1. Hikma also manufactures generic liraglutide in some markets. Pharmacy availability and pricing vary by region.

When will generic Victoza be available?

Estimated US generic availability: Available now (2024). This is an estimate based on USPTO Orange Book exclusivity and composition-of-matter patent expiry. In June 2024 the FDA approved Teva Pharmaceuticals' generic liraglutide injection 6 mg/mL — the first FDA-approved generic of any GLP-1. Hikma also manufactures generic liraglutide in some markets. Pharmacy availability and pricing vary by region.

Is compounded liraglutide the same as a generic?

No. Compounded products are prepared by licensed compounding pharmacies and are NOT FDA-approved as finished drugs. They have not undergone FDA bioequivalence testing and are not legally substitutable the way a true ANDA-approved generic would be.

Can I switch from Victoza to one of these alternatives on my own?

No. Switching GLP-1 medications requires a prescriber's clinical judgment about your indication, dose-titration history, side-effect tolerance, and insurance coverage. The alternatives listed here are options to DISCUSS with your prescriber — not recommendations.